Fiche centre
Kantonsspital Graubünden
Chur — Switzerland
Essais liés4clinical trials
VilleChurlocalisation
PaysSwitzerlandlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03993678
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Denosumab (reduced dosing) | Cancer | Phase 3 | NCT02051218 | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks | TERMINATED |
| Pumitamig | Cancer | Phase 1/2 | NCT07293351 | A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) | RECRUITING |
| IP-001 | Cancer | Phase 1/2 | NCT03993678 | Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. | COMPLETED |
| Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | SEP | À vérifier | NCT05017142 | Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | RECRUITING |